icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
Effect of DAA treatment on extrahepatic manifestations
incidence: a population-based study in British Columbia, Canada

 
 
  AASLD 2022 Nov 4-8
 
Dahn Jeong1,2, Stanley Wong1, Mohammad Ehsanul Karim2,3, Amee R Manges1,2, Héctor Alexander Velásquez García1,2, Mawuena Binka1,4, Sofia Bartlett1,5, Maryam Darvishian6, Prince Asumadu Adu1,2, Jean Damascene Makuza1,2, Hasina Samji1,7, Amanda Yu1, Maria Alvarez1, Mel Krajden1,5, Naveed Janjua1,2,3
 
1. British Columbia Centre for Disease Control, 2. School of Population and Public Health, University of British Columbia, 3. Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, 4. Faculty of Medicine, University of British Columbia, 5. Department of Pathology and Laboratory Medicine, University of British Columbia, 6. BC Cancer Agency, 7. Faculty of Health Sciences, Simon Fraser University

1121221

1121222

1121223

1121224

1121225